Pubblicazioni

IFNÎ² enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism

2019 - CELL DEATH & DISEASE

Vigo, Tiziana; La Rocca, Claudia; Faicchia, Deriggio; Procaccini, Claudio; Ruggieri, Maddalena; Salvetti, Marco; Centonze, Diego; Matarese, Giuseppe; Uccelli, Antonio

No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML

2017 - NEUROLOGY

Landi, Doriana; De Rossi, Nicola; Zagaglia, Sara; Scarpazza, Cristina; Prosperini, Luca; Albanese, Maria; Buttari, Fabio; Mori, Francesco; Marfia, Girolama Alessandra; Sormani, Maria Pia; Capra, Ruggero; Centonze, Diego; Italian, PML study group; Salvetti, Marco

A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials

2017 - SCIENTIFIC REPORTS

Eleuteri, Cecilia; Olla, S.; Veroni, Chiara; Umeton, Renato; Mechelli, Rosella; Romano, Silvia; Buscarinu, Maria Chiara; Ferrari, F.; Calo', Giorgia; Ristori, Giovanni; Salvetti, Marco; Agresti, C.

Trigeminal neuralgia: new classification and diagnostic grading for practice and research

2016 - NEUROLOGY

Cruccu, Giorgio; Finnerup, Nanna B; Jensen, Troels S; Scholz, Joachim; Sindou, Marc; Svensson, Peter; Treede, Rolf Detlef; Zakrzewska, Joanna M; Nurmikko, Turo

Distinct temporal fingerprint for cyclic adenosine monophosphate (cAMP) signaling of Indole-â2-âcarboxamides as allosteric modulators of the cannabinoid receptors

2015 - JOURNAL OF MEDICINAL CHEMISTRY

Cawston, Erin E.; Connor, Mark; Di Marzo, Vincenzo; Silvestri, Romano; Glass, Michelle